Cargando…
Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein
BACKGROUND: The F11R/JAM-A cell adhesion protein was examined as the therapeutic target in triple negative breast cancer (TNBC) with the use of the peptide antagonist to F11R/JAM-A, that previously inhibited the early stages of breast cancer metastasis in vitro. METHODS: The online in silico analysi...
Autores principales: | Bednarek, Radosław, Wojkowska, Dagmara W., Braun, Marcin, Watala, Cezary, Salifu, Moro O., Swiatkowska, Maria, Babinska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416405/ https://www.ncbi.nlm.nih.gov/pubmed/37563645 http://dx.doi.org/10.1186/s12935-023-03023-4 |
Ejemplares similares
-
Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment
por: Bednarek, Radoslaw, et al.
Publicado: (2019) -
In vivo data: treatment with the F11R/JAM-A peptide 4D decreases mortality and reduces the generation of atherosclerotic plaques in ApoE-deficient mice
por: Babinska, Anna, et al.
Publicado: (2020) -
The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression
por: Czubak-Prowizor, Kamila, et al.
Publicado: (2021) -
Time-dependent interactions of blood platelets and cancer cells, accompanied by extramedullary hematopoiesis, lead to increased platelet activation and reactivity in a mouse orthotopic model of breast cancer – implications for pulmonary and liver metastasis
por: Kassassir, Hassan, et al.
Publicado: (2020) -
SARS-CoV-2 Spike Protein and Neutralizing Anti-Spike Protein Antibodies Modulate Blood Platelet Function
por: Luzak, Boguslawa, et al.
Publicado: (2023)